NCT04741997 2026-03-02
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
H. Lee Moffitt Cancer Center and Research Institute
University of Utah
Grupo Español Multidisciplinar de Melanoma
Pierre Fabre Ltd
Herlev Hospital